The Fetal Medicine Foundation 18th World Congress in Fetal Medicine, Alicante, Spain
Abstracts
 
  • Aneuploidies
  • cfDNA test
  • Defects
    • CNS
    • Face
    • Heart
    • Lungs
    • Gastrointestinal
    • Kidneys
    • Skeleton
    • Tumors
    • Syndrome
    • Other
  • Fetal therapy
  • Impaired placentation
  • GDM / Obesity
  • Preterm birth
  • Congenital infection
  • Labour / Delivery
  • Maternal conditions
  • Multiple pregnancies
  • Other

Impaired placentation

  1. A case of large subchorionic hematoma with a normal pregnancy outcome View pdf
  2. A challenge of modern obstetrics ultrasound - Intrauterine growth restriction View pdf
  3. A maternal hetero-uniparental disomy 14 in a case with a small abdominal circumference and growth retardation View pdf
  4. Accuracy of Hadlock and Intergrowth Formula for Birthweight in pregnancies above 34 weeks with suspected IUGR View pdf
  5. Acute placental insufficiency in term and post term pregnancies with normal growth and dopplers View pdf
  6. Acute placental insufficiency in term and post-term gestation with normal fetal growth and normal umbilical artery Doppler View pdf
  7. Additive value of uterine Doppler in prediction of adverse perinatal outcome by cerebroplacental ratio View pdf
  8. Angiogenic factors and Dopplers for the prediction of adverse perinatal outcome in suspected small for gestational age View pdf
  9. Antepartum fetal surveillance by modified biophysical profile test View pdf
  10. Association of maternal Toll-Like Receptor-4 alleles with susceptibility to early preeclampsia View pdf
  11. Biochemical and biophysical markers for iugr screening of pregnant women View pdf
  12. Brain reorganitzation at neonatal period in a rabbit model of IUGR View pdf
  13. Changes in uterine and ophthalmic artery Doppler: a functional relationship uncovered by severe preeclampsia View pdf
  14. Chromosomal microarrays (CMA) in prenatal diagnosis: our experience in a tertiary hospital View pdf
  15. Contingent screening for preeclampsia in the first trimester: the additional value of placental growth factor View pdf
  16. Cost-effectiveness of the first screening center for preeclampsia in Mexico City View pdf
  17. Costs and management implications of severe early preeclampsia by sFlt-1: PlGF ratio View pdf
  18. CRL measurement at 7-14 weeks in IVF/ICSI pregnancies in frozen embryo versus fresh embryo transfers View pdf
  19. Customized growth chart of twins compared to singleton pregnancies View pdf
  20. Detection rate of small for gestational age fetuses using a routine third trimester ultrasound scan View pdf
  21. Early prophylactic Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction View pdf
  22. Effect of aspirin in the first trimester on the assessment of the uterine artery doppler in later trimesters View pdf
  23. Effect of high dose folic acid supplementation throughout pregnancy on preeclampsia View pdf
  24. Effect of selective fetal reduction in dichorionic twin pregnancies on the incidence of preeclampsia View pdf
  25. Endothelial function is impaired in pregnant women with intra-uterine growth restriction View pdf
  26. Establishing a differential marker profile for pregnancy complications near delivery View pdf
  27. Evaluation of fetal growth charts in detecting small for gestational age fetuses in the third trimester View pdf
  28. Evaluation of predictive capacity of the IPmAUt 1st t in relation to IGR in Universitary Hospital of Fuenlabrada View pdf
  29. Evaluation of sFlt-1/PlGF ratio in the diagnosis and classification of preeclampsia View pdf
  30. Featl distress in labour in cases of fetal growth restriction View pdf
  31. Fetal and placental tissue characterisation in lung maturity in preeclamptic and diabetic patients View pdf
  32. Fetal cardiac remodeling and dysfunction is associated with both preeclampsia and intrauterine growth restriction View pdf
  33. Fetal growth restriction. Experience of a secondary medical center View pdf
  34. Fetal pleural effusion: Contemporary methods of genetic evaluation View pdf
  35. Fetal thymus volume in 11-14 week pregnancy and development of preeclampsia View pdf
  36. Fetal weight estimation before delivery - experience of the author's novel method application View pdf
  37. Fetoplacental Doppler for the identification of cardiac dysfunction in small for gestational age fetuses View pdf
  38. Fetoplacental Doppler identifies small for gestational age fetuses with increased fetal erythropoietin concentrations View pdf
  39. First trimester uterine artery Doppler: comparison between sagittal and transverse techniques View pdf
  40. Frequency of IGR according to the evolution of the IPmAUt in 2nd trimester in University Hospital of Fuenlabrada View pdf
  41. Frequency of preeclampsia according to uterine evolution in second trimester View pdf
  42. Frequency of premature labour in relation to PE and FGR in University Hospital of Fuenlabrada View pdf
  43. Frozen versus fresh embryo transfers and fetal growth View pdf
  44. Frozen versus fresh embryo transfers and uterine perfusion and fetal growth View pdf
  45. Hemopexin and alpha-1-microglobulin involvement in preeclampsia and/or fetal growth restriction View pdf
  46. Identification of phenotypes of fetal growth restriction based using a metabolomics network-based clustering approach View pdf
  47. IMPACT Barcelona: Improving Mothers for a better PrenAtal Care Trial. A RCT to reduce fetal growth restriction View pdf
  48. Incorporating fetal growth trajectory in the prediction of fetal weight View pdf
  49. INTERGROWTH 21 vs customized curves to predict neonatal nutritional status in hypertensive disorders of pregnancy View pdf
  50. INTERGROWTH 21 vs customized fetal growth curves in the assessment of the neonatal nutritional status View pdf
  51. Is cardiac maladaptation a risk factor for pregnancy View pdf
  52. Limited added value of cerebroplacental ratio in predicting adverse perinatal outcome View pdf
  53. Long-term cardiovascular effects of obstetric complications on maternal health View pdf
  54. Low level of PAPP-A in chromosomally normal fetuses View pdf
  55. Maternal and neonatal outcomes of semi-intensive monitoring of pre eclampsia with severity criteria View pdf
  56. Maternal and perinatal outcomes associated with extremely high values of the sFlt-1/PlGF ratio View pdf
  57. Maternal characteristics in case of abnormal and normal uterine artery dopplers in the first trimester View pdf
  58. Maternal serum levels of PlGF and sFlt-1 in a low-risk population in the third trimester to predict fetal growth restriction View pdf
  59. Maternal serum levels of PlGF and sFlt-1 in a low-risk population of pregnant women in predicting delivery of an SGA newborn View pdf
  60. MCA and CPR for the prediction of blood oxygen level-dependent signal evaluated by functional resting state MRI View pdf
  61. Measurement of the pulsatility index of the uterine arteries as a screening method to predict late intrauterine growth restriction View pdf
  62. Metabolomic profiling of paired maternal and cord blood in preeclampsia and fetal growth restriction View pdf
  63. MicroRNA-148b-3p and MicroRNA-25-3p are overexpressed in fetuses with late-onset fetal growth restriction View pdf
  64. Multivariate predictive model of vaginal delivery in labour induction of late-onset fetal growth restriction View pdf
  65. Neurodevelopmental damage in FGR studies by a rabbit neurosphere model View pdf
  66. Perinatal outcome in pregnancies with severe early growth restriction View pdf
  67. Perinatal outcomes of IUGR diagnosed prenataly vs those that were not diagnosed prenataly View pdf
  68. Perinatal results in FGR fetuses attending to Doppler alteration View pdf
  69. Placental deterioration may precede fetal loss by early first-trimester parameters in IVF pregnancies View pdf
  70. Placental perfusion assesed by MR IVIM and its correlation with placental volume in fetal growth restriction at term View pdf
  71. PLGF and PAPPA levels for first trimester preeclampsia screening View pdf
  72. Postpartum cardiovascular/cerebrovascular disease associated microRNAs in women with pregnancy complications View pdf
  73. Pravastatin to treat early-onset fetal growth restriction View pdf
  74. Prediction of fetal compromise by cerebroplacental ratio, Intergrowth-21st, customized growth and local population references View pdf
  75. Prediction of one-week delivery in early onset stage-I fetal growth restriction View pdf
  76. Prediction of preeclampsia by first trimester uterine artery Dopplers View pdf
  77. Prediction of preterm delivery in patients with late-onset preeclampsia or fetal growth restriction using the FMF calculator View pdf
  78. Prediction of small-for-gestational age: added contribution of second to third trimester growth velocity View pdf
  79. Predictive value of sFLT-1 / PlGF ratio for late-onset fetal growth restriction View pdf
  80. Prevalence and sociodemographic aspects of hypertensive disorders in pregnancy and maternal, perinatal outcomes View pdf
  81. Prevalence of fetal growth restriction: single-center experience View pdf
  82. Prevalence of maternal preeclampsia pre and post ASPRE era in a South Indian urban population View pdf
  83. Pulsatility index of the middle cerebral artery in the third trimester and maternal position over time View pdf
  84. Relationship between placental biometry, uterine artery Doppler and biochemical markers in the first trimester View pdf
  85. Results of preeclampsia screening test in aspirin users patients View pdf
  86. Role of biochemical markers for predicting short-term delivery in preeclampsia View pdf
  87. Role of uterine artery doppler evaluation in second trimester of pregnancy in women at high risk of preeclampsia View pdf
  88. Screening of preeclampsia and intrauterine growth restriction at 11-14 weeks’ gestation View pdf
  89. Severe fetal-growth restriction and normal doppler: neurodevelopmental evaluation at 54 months of age View pdf
  90. Skeletal muscle tissue oxygenation in pregnant women, effects of preeclampsia and peripheral oedema View pdf
  91. Spot albumin: creatinine ratio and protein: creatinine ratio should replace the outdated 24 hour collection View pdf
  92. Targeted lipidomics of paired maternal and fetal plasma in preeclampsia and/or fetal growth restriction View pdf
  93. The association between the diagnosis of fetal growth restriction and maternal antenatal stress View pdf
  94. The concentrations of placental growth factor and endoglin in pregnancies complicated by preeclampsia View pdf
  95. The impact of sFlt-1/PlGF ratio in preeclampsia diagnosis in symptomatic patients View pdf
  96. The influence of prenatal chromosomal microarray analysis on the decision of termination of pregnancy View pdf
  97. The involvement of complement and coagulation cascades in early onset pre eclampsia revealed by maternal proteomics View pdf
  98. The use of microfluidic technology to capture fetal cells in maternal circulation View pdf
  99. The use of microfluidic technology to isolate cultured trophoblasts: controlled spike-in experiments View pdf
  100. The value of umbilical artery Doppler for the prediction of adverse perinatal outcome in women with preeclampsia View pdf
  101. Third trimester maternal serum levels of PlGF and sFlt-1 in predicting preeclampsia View pdf
  102. Treatment with low molecular weight heparin in primiparous patients with recurrent pregnancy loss View pdf
  103. Twin-specific longitudinal doppler nomograms in uncomplicated monochorionic twins and comparison with singletons View pdf
  104. Use of routine fetal growth charts in early and late third trimester in predicting small fetuses and adverse perinatal outcomes View pdf
  105. Use of the sFlt-1/PlGF ratio as a supplement in the diagnosis and management of pre eclampsia View pdf
  106. Usefulness of middle cerebral artery peak systolic velocity in assessing reduced fetal movements View pdf
  107. Uterine arteries pulsatility indices as a predictor of preeclampsia in single pregnancies in the three trimesters of gestation View pdf
  108. Uterine artery doppler changes as predictors of preeclampsia View pdf
  109. Uterine artery doppler, cerebroplacental ratio and fetal growth in the late third trimester: association with adverse outcome View pdf
  110. Uterine artery pulsatility index assessment at <11 weeks gestation: A prospective study View pdf
33303637368734803753377032393358364637343700342736103674352736243503366333503672359936963347362033323716327832003611359433873452364237073324349435113510335932013409320236833659345635093476347336193616343831663163347234103345337233643361364136453459324033433426369935843334331833573694314933823238334234083344332333353697328837503661362933673368331637033422317137103458351431603543355434573749374833533363367836543769356333033729373035473150
© 2019 The Fetal Medicine Foundation